Bioinformatics outsourcing poised for growth
Outsourcing is expected to emerge as a definitive trend in the bioinformatics industry, according to a new report by Frost & Sullivan.
Archives for September 18, 2006
MedImmune in $250m biologics plant expansion
MedImmune has embarked on an expansion of its biologics manufacturing facility in Frederick, Maryland, to ramp up its cell culture production capacity, as several of its monoclonal antibodies (MAbs) approach commercialisation.
Cardinal gets green light for new sterile facility start-up
Cardinal Health has been given the green light from the US Food and Drug Administration (FDA) to start manufacturing the first commercial drug at its new sterile facility in North Carolina.
Reaxa scavenges for contaminants
Catalyst specialist Reaxa has launched the latest flight of additions to its range of metal scavenging products for pharma process applications which can be used in both batch and continuous processing.
Bioxel gears up for supply of docetaxel to generic drugmakers
Canadian firm Bioxel has manufactured the first industrial-scale current good manufacturing practice (cGMP) batch of its key intermediate for docetaxel, the active pharmaceutical ingredient (API) of Sanofi-Aventis's blockbuster chemotherapy drug...